0 0 0 0 0.00116845180136324 -0.00681596884128532 -0.011684518013632 -0.0147517039922103
Thanks for submitting the form.
Stockreport

Trevi Therapeutics appoints new CFO [Seeking Alpha]

Incyte Corporation (INCY)  More Company Research Source: Seeking Alpha
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Hastings prior roles include CFO positions at Arbutus, Unilife, and Incyte. Hastings currently serves on the board and chairs the audit committee of Scynexis. More on Trevi Therapeutics Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond Trevi Therapeutics: Big Cough Data, Bigger Execution Risk Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript Trevi Therapeutics edges higher amid takeover speculation Trevi Therapeutics targets multiple phase III trial launches for chronic cough indications in 2026 as regulatory plans accelerate Recommended For You More Trending News [Read more]

IMPACT SNAPSHOT EVENT TIME: INCY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

Trevi Therapeutics appoints new CFO [Seeking Alpha]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
Hastings prior roles include CFO positions at Arbutus, Unilife, and Incyte. Hastings currently serves on the board and chairs the audit committee of Scynexis. More on Trevi Therapeutics Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond Trevi Therapeutics: Big Cough Data, Bigger Execution Risk Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript Trevi Therapeutics edges higher amid takeover speculation Trevi Therapeutics targets multiple phase III trial launches for chronic cough indications in 2026 as regulatory plans accelerate Recommended For You More Trending News [Read more]

IMPACT SNAPSHOT
EVENT TIME:
INCY
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS